OBIO and MDT Related Headlines

Go Back

Aug 10, 2026 04:12PM Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 04:18PM Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 08:30AM Orchestra BioMed targets BACKBEAT trial completion by Q3 2026
May 12, 2026 08:30AM Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 6, 2026 08:03AM Orchestra BioMed receives $20 million from Medtronic under financing pact
May 6, 2026 08:01AM Orchestra BioMed receives $15 million from Ligand under financing agreement
May 6, 2026 08:01AM Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026 08:00AM Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Apr 30, 2026 09:00AM FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Apr 23, 2026 12:00PM Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12, 2026 08:17AM Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Nov 11, 2025 09:00AM Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Nov 10, 2025 04:10PM Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

OBIO and MDT Related Press Releases

Go Back

Aug 10, 2026 04:12PM Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 04:18PM Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026 08:30AM Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 6, 2026 08:01AM Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026 08:00AM Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Apr 30, 2026 09:00AM FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Apr 23, 2026 12:00PM Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12, 2026 08:17AM Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Nov 11, 2025 09:00AM Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Nov 10, 2025 04:10PM Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

OBIO and MDT Related SEC Filings

Go Back